Haemonetics Corporation (HAE) Financials

HAE Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 2.4 billion 1.5 billion
March 31, 2026 2.4 billion 1.6 billion
Dec. 31, 2025 2.5 billion 1.6 billion
Sept. 30, 2025 2.4 billion 1.6 billion

HAE Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 44.4 million 9.3 million
March 31, 2026 53.3 million 9.1 million
Dec. 31, 2025 87.2 million 7.8 million
Sept. 30, 2025 106.3 million 7.6 million

HAE Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 33.0 million
March 31, 2026 -20.1 million
Dec. 31, 2025 44.7 million
Sept. 30, 2025 38.7 million

HAE Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 223.4 million 1.2 billion -
March 31, 2026 245.4 million 1.2 billion -
Dec. 31, 2025 363.4 million 920.0 million -
Sept. 30, 2025 296.4 million 920.4 million -

HAE Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 45.7 million
March 31, 2026 46.2 million
Dec. 31, 2025 47.0 million
Sept. 30, 2025 47.7 million

HAE Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 7.9 million 16.2 million 118.9 million -
March 31, 2026 17.7 million 14.4 million 121.8 million -
Dec. 31, 2025 6.3 million 14.3 million 107.6 million -
Sept. 30, 2025 5.0 million 14.5 million 101.6 million -

HAE Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 339.4 million 136.6 million
March 31, 2026 346.4 million 148.1 million
Dec. 31, 2025 339.0 million 147.6 million
Sept. 30, 2025 327.3 million 143.9 million

HAE Revenue by Segment

Graph available only for paid members. Upgrade to see it.

HAE

Price: $120.88

52 week price:
48.17
122.06

Earnings Per Share: 2.16 USD

P/E Ratio: 42.29

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 121503

Ebitda: 23.3 million

Market Capitalization: 4.7 billion

Links: